Clinical Trials Logo

Clinical Trial Summary

This research will test whether a Dietary Approaches to Stop Hypertension (DASH) or a very low-carbohydrate diet better improves outcomes like blood glucose control and body weight for adults with polycystic ovary syndrome. Participants will have screening (includes blood draw) and baseline testing with a continuous glucose monitor and a body composition scan (called a dual-energy x-ray absorptiometry or DEXA). Once these enrollment steps are completed and the participants will be randomized to one of two 12-month programs.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05452642
Study type Interventional
Source University of Michigan
Contact Laura Saslow, PhD
Phone 734-764-7836
Email saslowl@umich.edu
Status Recruiting
Phase N/A
Start date August 15, 2022
Completion date October 14, 2026

See also
  Status Clinical Trial Phase
Not yet recruiting NCT06405178 - Adjuvant Therapy With Letrozole in Induction of Ovulation With Polycystic Ovarian Syndrome Phase 3
Not yet recruiting NCT06428786 - The Effect of Polycystic Ovary Syndrome Phenotypes on Quality of Life and Sexual Function
Not yet recruiting NCT05965908 - Effect of Liraglutide in Obese Women With Polycystic Ovary Syndrome Phase 3
Recruiting NCT03819998 - Serum Fetuin Level in Polycystic Ovary Syndrome
Completed NCT04231786 - Breast Ultrasonography and Polycystic Ovary Syndrome
Completed NCT04448730 - Polycystic Ovary Syndrome and BETATROPHIN
Completed NCT05062135 - Progesterone Action on Endometrium of PCOS N/A
Recruiting NCT03178500 - Clomiphene Citrate Stair-Step Protocol N/A
Completed NCT03871868 - Vitamin D Levels And Myoma Uteri
Not yet recruiting NCT02087410 - Serum Ghrelin in Polycystic Ovary Syndrome N/A